Laurus Labs Limited
LAURUSLABS
Hisse Senetlerindeki Sıralama
#1745
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Hisse Fiyatı
$22.83
Son senkronizasyon: 2026-10-19
Piyasa Değeri
$12.34B
Değişim (1 gün)
0.51%
Değişim (1 yıl)
117.95%
Ülke
IN
Ticaret Laurus Labs Limited (LAURUSLABS)
Kategori
Healthcare
Laurus Labs Limited (LAURUSLABS) için P/B oranı
October 2026 itibarıyla P/B oranı TTM: 20.22
Laurus Labs Limited şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 20.22'dir. 2024 yılının sonunda şirketin P/B oranı 5.33 idi.
Laurus Labs Limited için P/B oranı geçmişi 2013 - 2026 arası
Her yılın sonunda P/B oranı
| Yıl | P/B Oranı | Değiştir |
|---|---|---|
| 2026 (TTM) | 20.22 | 179.62% |
| 2025 | 7.23 | 35.60% |
| 2024 | 5.33 | 36.58% |
| 2023 | 3.90 | -58.72% |
| 2022 | 9.45 | 26.60% |
| 2021 | 7.47 | 281.34% |
| 2020 | 1.96 | -27.51% |
| 2019 | 2.70 | -25.65% |
| 2018 | 3.63 | 3.43% |
| 2017 | 3.51 | -22.67% |
| 2016 | 4.54 | 10.34% |
| 2015 | 4.12 | -49.81% |
| 2014 | 8.20 | -45.55% |
| 2013 | 15.06 | 0.00% |
Benzer şirketler veya rakipler için P/B oranı
| Şirket | P/B Oranı | P/B Oranı Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -75.07% |
IN
|
